The Vital Insights from Bristol Myers Squibb (BMY) Q3 2024 Earnings Report

Thursday, 31 October 2024, 12:53
Bristol Myers Squibb results for Q3 2024 reveal total revenues of $11.9 billion, an 8% year-over-year increase. Earnings per share declined to $0.60 from $0.93 last year. The company forecasts a 5% revenue growth for the year.
Alphastreet
The Vital Insights from Bristol Myers Squibb (BMY) Q3 2024 Earnings Report

Revenue and Earnings Overview

Bristol Myers Squibb (NYSE: BMY) showcased significant growth in its Q3 2024 earnings report, highlighting total revenues reaching $11.9 billion, marking an 8% year-over-year increase. Adjusted earnings per share (EPS) have dropped to $1.80, down by 10% from the previous year.

Future Projections

  • Full-year 2024 revenue growth is expected to be around 5% YoY.
  • Adjusted EPS projections range between $0.75 and $0.95.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe